Similar Articles
1211 Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort
1212 Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
1213 CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma
1214 What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis
1215 Association between COX-2 -1195G>A polymorphism and gastrointestinal cancer risk: A meta-analysis
1216 Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
1217 Case of hepatocellular carcinoma in a patient with hereditary tyrosinemia in the post-newborn screening era
1218 Consequences of bullying victimization in childhood and adolescence: A systematic review and meta-analysis
1219 Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy
1220 Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA